Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The macular pigment is a specialized biological filter located in the central retina, composed of the dietary xanthophyll carotenoids lutein, zeaxanthin, and meso-zeaxanthin (Bernstein et al., 2016). It serves a dual protective role by absorbing high-energy, short-wavelength blue light (400–500 nm) and acting as a powerful antioxidant to neutralize reactive oxygen species generated by light-induced oxidative stress (Arunkumar et al., 2018). These pigments are concentrated in the Henle fiber layer of the macula, the area responsible for high-acuity central vision, where they protect the photoreceptors and retinal pigment epithelium from cumulative damage. Low levels of macular pigment, measured as macular pigment optical density (MPOD), are strongly associated with an increased risk of developing age-related macular degeneration (AMD) (NIH/NEI AREDS2). Consequently, the macular pigment is a primary target for nutritional interventions, with clinical evidence supporting the use of lutein and zeaxanthin supplementation to slow the progression of advanced AMD and improve visual performance metrics like contrast sensitivity and glare recovery.
Absorption of high-energy blue light (400-500 nm) and quenching of reactive oxygen species to prevent photo-oxidative damage to the retina.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macular pigment (MP) (MP).